Pathomorphological Features of Placenta in Different Degrees of Severity of New Coronavirus Infection Suffered During Pregnancy

Abstract

INTRODUCTION: A wide spread of infection caused by SARS-CoV-2 coronavirus (Severe Acute Respiratory Syndrome-related coronavirus 2 associated with a severe acute respiratory syndrome) in the population, high risks of infection in pregnant women and the lack of understanding of the mechanisms of invasion of the agent into the placenta and its effect on the perinatal outcomes, dictate the need for targeted investigation of the morphofunctional features of placentas of puerperia’s who have suffered this infection.

AIM: To identify pathomorphological alterations in placentas in a mild, moderate and severe course of the new coronavirus infection in women during pregnancy.

MATERIALS AND METHODS: A morphological survey research of 63 placentas of women who have suffered SARS-CoV-2 infection during pregnancy was conducted. The material was divided into groups with mild (n = 16), moderate (n = 35) and severe (n = 12) course of the disease. The control group included 25 placentas from women with physiological pregnancy. After standard fixation and histological preparation of the material, the tissue sections of 4 µm to 5 µm thickness were stained with hematoxylin and eosin.

RESULTS: It has been established that the new coronavirus infection runs with general pathological alterations in the placentas. In a mild course of the infectious process, inflammation in the basal (12.5%) and parietal (25.0%) decidual membrane, disorders in maternal (6.3%) and fetal (6.3%) hemocirculation were diagnosed. A moderate course of the disease was characterized by predominance of placentas with impaired differentiation of chorionic villi by dissociation type (74.3%, p = 0.0001) and of mononuclear deciduitis (57.1%, p = 0.008). In a severe course of SARS-CoV-2 infection, abnormalities in the form of placenta (58.3%, p = 0.004) and in the attachment of the umbilicus (58.3%, p = 0.03), villous infarctions (33.3%, p = 0.05), thrombosis in the maternal (63.7%, p = 0.005) and fetal (57.3%, p = 0.005) parts of vascular bed were noted.

CONCLUSION: Thus, the mild course of SARS-CoV-2 infection is characterized by chronic inflammation in the structural components of the placenta, the moderate course — by the dissociated development of cotyledons, the severe course — by disorders in hemocirculation in the form of infarctions and thrombosis.

Keywords

SARS-CoV-2 / COVID-19 / pregnancy / placenta

References

[1] Wenling Y, Junchao Q., Xiao Z., Ouyang S. Pregnancy and COVID-19: management and challenges. Rev Inst Med Trop Sao Paulo. 2020;62:e62. doi: 10.1590/s1678-9946202062062

[2] Wenling Y., Junchao Q., Xiao Z., et al. Pregnancy and COVID-19: management and challenges// Rev. Inst. Med. Trop. Sao Paulo. 2020. Vol. 62. P. e62. doi: 10.1590/s1678-9946202062062

[3] Adamyan LV, Vechorko VI, Filippov OS, et al. Maternity care during coronavirus epidemic. Russian Journal of Human Reproduction. 2020;26(5):8–16. (In Russ). doi: 10.17116/repro2020260518

[4] Адамян Л.В., Вечорко В.И., Филиппов О.С., и др. Особенности родовспоможения у беременных коронавирусной инфекцией // Проблемы репродукции. 2020. Т. 26, № 5. С. 8–16. doi: 10.17116/repro2020260518

[5] Novoa RH, Quintana W, Llancari P, et al. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review. Travel Med Infect Dis. 2021;39:101919. doi: 10.1016/j.tmaid.2020.101919

[6] Novoa R.H., Quintana W., Llancari P., et al. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review // Travel. Med. Infect. Dis. 2021. Vol. 39. P. 101919. doi: 10.1016/j.tmaid.2020.101919

[7] Guan W–J, Ni Z–Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. doi: 10.1056/nejmoa2002032

[8] Guan W.–J., Ni Z.–Y., Hu Y., et al.Clinical Characteristics of Coronavirus Disease 2019 in China // N. Engl. J. Med. 2020. Vol. 382, No. 18. P. 1708–1720. doi: 10.1056/nejmoa2002032

[9] Smirnov AV, Poplavsky AE, Chernyshev NV, et al. On the possibility of penetration of SARS-CoV-2 through the hematoplacental barrier (clinical and pathoanatomical study). Volgogradskiy Nauchno-Meditsinskiy Zhurnal. 2021;(1):52–7. (In Russ).

[10] Смирнов А.В., Поплавский А.Э., Чернышев Н.В., и др. К вопросу о возможности проникновения SARS-Cov-2 через гематоплацентарный барьер (клинико-патологоанатомическое исследование) // Волгоградский научно-медицинский журнал. 2021. № 1. С. 52–57.

[11] Zamaniyan M, Ebadi A, Aghajanpoor S, et al. Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection. Prenat Diagn. 2020;40(13):1759–61. doi: 10.1002/pd.5713

[12] Zamaniyan M., Ebadi A., Aghajanpoor S., et al. Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection // Prenat. Diagn. 2020. Vol. 40, No. 13. P. 1759–1761. doi: 10.1002/pd.5713

[13] Efremova NV, Rumyantseva ZS, Sulima AN,et al.Synctial nodes as a marker of the state of the microcirculator complex mother-placentafoetus in SARS-CoV-2. Far Eastern Medical Journal. 2022;(3):96–103. (In Russ). doi: 10.35177/1994-5191-2022-3-16

[14] Ефремова Н.В., Румянцева З.С., Сулима А.Н., и др. Синцитиальные узелки как маркер состояния микроциркуляторного комплекса мать-плацента-плод при SARS-CoV-2 // Дальневосточный медицинский журнал. 2022. № 3. С. 96–103. doi: 10.35177/1994-5191-2022-3-16

[15] Shchegolev AI, Tumanova UN, Serov VN. Placental lesions in pregnant women with SARS-CoV-2 infection. Obstetrics and Gynecology. 2020;(12):44–52. (In Russ). doi: 10.18565/aig.2020.12.44-52

[16] Щеголев А.И., Туманова У.Н., Серов В.Н. Поражения плаценты у беременных с SARS-CoV-2-инфекцией // Акушерство и гинекология. 2020. № 12. С. 44–52. doi: 10.18565/aig.2020.12.44-52

[17] Gulersen M, Prasannan L, Tam Tam H, et al. Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection. Am J Obstet Gynecol MFM. 2020;2(4):100211. doi: 10.1016/j.ajogmf.2020.100211

[18] Gulersen M., Prasannan L., Tam Tam H., et al. Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection // Am. J. Obstet. Gynecol. MFM. 2020. Vol. 2, No. 4. P.100211. doi: 10.1016/j.ajogmf.2020.100211

[19] Shanes ED, Mithal LB, Otero S, et al. Placental Pathology in COVID-19. Am J Clin Pathol. 2020;154(1):23–32. doi: 10.1093/ajcp/aqaa089

[20] ShanesE.D., MithalL.B., OteroS., et al. Placental Pathology in COVID-19 // Am. J. Clin.Pathol. 2020. Vol. 154, No. 1. P. 23–32. doi: 10.1093/ajcp/aqaa089

[21] Voennov OV, Zagrecov VI, Boyarinov GA, et al. Mechanisms of pulmonary injury development in patients with new coronavirus infection (literature review). Medical Almanac. 2020;(3):15–26. (In Russ).

[22] Военнов О.В., Загреков В.И., Бояринов Г.А., и др. Механизмы развития легочного повреждения у пациентов с новой коронавирусной инфекцией (обзор литературы) // Медицинский альманах. 2020. № 3 (64). С. 15–26.

[23] Nizyaeva NV, Lomova NA, Dolgopolova EL, et al. The impact of the novel coronavirus infection COVID-19 on the mother-placenta-fetus system. Bulletin of RSMU. 2021;(2):27–34. (In Russ). doi: 10.24075/vrgmu.2021.020

[24] Низяева Н.В., Ломова Н.А., Долгополова Е.Л., и др. Влияние новой коронавирусной инфекции COVID-19 на систему «мать-плацента-плод» // Вестник РГМУ. 2021. № 2. С. 27–34. doi: 10.24075/vrgmu.2021.020

[25] Altshuler G, Russell P. The human placental villitides: a review of chronic intrauterine infection. Curr Top Pathol. 1975;60:64–112.

[26] Altshuler G., Russell P. The human placental villitides: a review of chronic intrauterine infection // Curr. Top. Pathol. 1975. Vol. 60. P. 64–112.

[27] Kasparova AE, Sheludko VS, Vasilkovskaya EN. Loss of pregnancy in the conditions of the COVID-19 pandemic. In: Fundamental’nyye i prikladnyye problemy zdorov’yesberezheniya cheloveka na Severe: sbornik materialov V Vserossiyskoy nauchno-prakticheskoy kon-ferentsii; Surgut, 27 October 2020. Surgut; 2020. P. 348–55. Available at: https://www.surgu.ru/attachment/27156/download/Sbornik_zdoroviesberezhenie_2020-02-03-21.pdf. Accessed: 2023 April 18. (In Russ).

[28] Каспарова А.Э. Шелудько В.С., Васильковская Е.Н. Невынашивание беременности в условиях пандемии COVID-19. В сб.: Фундаментальные и прикладные проблемы здоровьесбережения человека на Севере: сборник материалов V Всероссийской научно-практической конференции; Сургут, 27 октября 2020 года.Сургут; 2020. С. 348–355. Доступно по: https://www.surgu.ru/attachment/27156/download/Sbornik_zdoroviesberezhenie_2020-02-03-21.pdf. Ссылка активна на 18.04.2023.

[29] Facchetti F, Bugatti M, Drera E, et al. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta. EBioMedicine. 2020;59:102951. doi: 10.1016/j.ebiom.2020.102951

[30] Facchetti F., Bugatti M., Drera E., et al. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta // EBioMedicine. 2020. Vol. 59. P. 102951. doi: 10.1016/j.ebiom.2020.102951

[31] Vivanti AJ, Vauloup–Fellous C, Prevot S, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11(1):3572. doi: 10.1038/s41467-020-17436-6

[32] Vivanti A.J., Vauloup–Fellous C., Prevot S., et al. Transplacental transmission of SARS-CoV-2 infection // Nat.Commun. 2020. Vol. 11, No. 1. P. 3572. doi: 10.1038/s41467-020-17436-6

RIGHTS & PERMISSIONS

Eco-Vector